Impact of macronutrient supplements for children born preterm or small for gestational age on developmental and metabolic outcomes: A systematic review and meta-analysis
Open Access
- 30 October 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 16 (10) , e1002952
Abstract
Nutritional supplements may improve development of infants born small (preterm or small for gestational age [SGA]) but may increase the risk of later metabolic disease. We conducted a systematic review and meta-analysis to assess the effects of macronutrient supplements for infants born small on later development and metabolism. We searched OvidMedline, Embase, Cochrane CENTRAL, and Cochrane Database of Systematic Reviews from inception to April 1, 2019, and controlled-trials.com, clinicaltrials.gov, and anzctr.org.au. Randomised or quasirandomised trials were included if the intention was to increase macronutrient intake to improve growth or development of infants born small and assessed post-discharge outcomes. Co-primary outcomes were cognitive impairment and metabolic risk, evaluated in toddlers ( 0.05). However, supplemented children had lower fasting glucose (mmol/L: MD −0.20; 95% CI −0.34 to −0.06; P = 0.005) and higher high-density lipoprotein (HDL) concentrations (mmol/L: MD 0.11; 95% CI 0.02 to 0.19; P = 0.02). In subgroup analyses, there was no evidence of differences in blood pressure between supplemented and unsupplemented groups in boys or girls born small, or in SGA children. In adolescence, there was no difference between supplemented and unsupplemented groups in blood pressure, triglycerides, LDL and HDL concentrations, fasting blood glucose, insulin resistance, and fasting insulin concentrations (all P > 0.05). Limitations include considerable unexplained heterogeneity, low to very low quality of the evidence, and limited data beyond early childhood. In this systematic review and meta-analysis of randomised trials, we found no evidence that early macronutrient supplementation for infants born small altered later cognitive function, although there was some evidence that supplementation may decrease motor impairment in toddlers. Contrary to the findings from observational studies, evidence from randomised trials suggests that early macronutrient supplementation for infants born small improves some metabolic outcomes in childhood. CRD42019127858.Keywords
Funding Information
- Health Research Council of New Zealand (16/605)
This publication has 51 references indexed in Scilit:
- Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low- and middle-income countriesInternational Journal of Epidemiology, 2013
- Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysisThe Lancet, 2013
- Infant Growth Before and After Term: Effects on Neurodevelopment in Preterm InfantsPediatrics, 2011
- Early Diet and General Cognitive Outcome at Adolescence in Children Born at or Below 30 Weeks GestationThe Journal of Pediatrics, 2009
- Attention should be given to multiplicity issues in systematic reviewsJournal of Clinical Epidemiology, 2008
- How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?Archives of Disease in Childhood, 2008
- Improving head growth in very preterm infants – a randomised controlled trial I: neonatal outcomesArchives of Disease in Childhood - Fetal and Neonatal Edition, 2008
- Rapid infancy weight gain and subsequent obesity: Systematic reviews and hopeful suggestionsActa Paediatrica, 2006
- A randomised multicentre study of human milk versus formula and later development in preterm infants.Archives of Disease in Childhood - Fetal and Neonatal Edition, 1994
- Clinical effects of two different levels of protein intake on low-birth-weight infantsThe Journal of Pediatrics, 1969